These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15154605)

  • 1. Immunopathological basis of virus-induced myocarditis.
    Maier R; Krebs P; Ludewig B
    Clin Dev Immunol; 2004 Mar; 11(1):1-5. PubMed ID: 15154605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy.
    Massilamany C; Gangaplara A; Reddy J
    Int J Cardiol; 2014 Dec; 177(2):330-339. PubMed ID: 25449464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The outcome of coxsackievirus B3-(CVB3-) induced myocarditis is influenced by the cellular immune status.
    Leipner C; Grün K; Borchers M; Stelzner A
    Herz; 2000 May; 25(3):245-8. PubMed ID: 10904846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis.
    Guo Y; Wu W; Cen Z; Li X; Kong Q; Zhou Q
    Virol J; 2014 Dec; 11():230. PubMed ID: 25547181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Coxsackievirus B3-Induced Immune Responses in the Transition from Myocarditis to Dilated Cardiomyopathy and Heart Failure.
    Yip F; Lai B; Yang D
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coxsackievirus B3 infection leads to the generation of cardiac myosin heavy chain-α-reactive CD4 T cells in A/J mice.
    Gangaplara A; Massilamany C; Brown DM; Delhon G; Pattnaik AK; Chapman N; Rose N; Steffen D; Reddy J
    Clin Immunol; 2012 Sep; 144(3):237-49. PubMed ID: 22854287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein Kinase B2 (PKB2/AKT2) Is Essential for Host Protection in CVB3-Induced Acute Viral Myocarditis.
    Kim SH; Shin HH; Kim JH; Park JH; Jeon ES; Lim BK
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular bases for the immunopathology of the myocardial cell damage involved in acute viral myocarditis with special reference to dilated cardiomyopathy.
    Seko Y; Yamazaki T; Shinkai Y; Yagita H; Okumura K; Naito S; Imataka K; Fujii J; Yazaki Y
    Jpn Circ J; 1992 Oct; 56(10):1062-72. PubMed ID: 1331556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the understanding of myocarditis.
    Liu PP; Mason JW
    Circulation; 2001 Aug; 104(9):1076-82. PubMed ID: 11524405
    [No Abstract]   [Full Text] [Related]  

  • 10. Enterovirus-infected immune cells of spleen and lymph nodes in the murine model of chronic myocarditis: a role in pathogenesis?
    Klingel K; McManus BM; Kandolf R
    Eur Heart J; 1995 Dec; 16 Suppl O():42-5. PubMed ID: 8682099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connective tissue growth factor: a crucial cytokine-mediating cardiac fibrosis in ongoing enterovirus myocarditis.
    Lang C; Sauter M; Szalay G; Racchi G; Grassi G; Rainaldi G; Mercatanti A; Lang F; Kandolf R; Klingel K
    J Mol Med (Berl); 2008 Jan; 86(1):49-60. PubMed ID: 17846733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy.
    Rahnefeld A; Klingel K; Schuermann A; Diny NL; Althof N; Lindner A; Bleienheuft P; Savvatis K; Respondek D; Opitz E; Ketscher L; Sauter M; Seifert U; Tschöpe C; Poller W; Knobeloch KP; Voigt A
    Circulation; 2014 Oct; 130(18):1589-600. PubMed ID: 25165091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of the immune mechanisms of viral myocarditis.
    Lasrado N; Reddy J
    Rev Med Virol; 2020 Nov; 30(6):1-14. PubMed ID: 32720461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coxsackievirus B3-induced myocarditis: differences in the immune response of C57BL/6 and Balb/c mice.
    Leipner C; Grün K; Schneider I; Glück B; Sigusch HH; Stelzner A
    Med Microbiol Immunol; 2004 May; 193(2-3):141-7. PubMed ID: 14593475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CD1d in coxsackievirus B3-induced myocarditis.
    Huber S; Sartini D; Exley M
    J Immunol; 2003 Mar; 170(6):3147-53. PubMed ID: 12626572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice.
    Huber SA; Feldman AM; Sartini D
    Circ Res; 2006 Nov; 99(10):1109-16. PubMed ID: 17038643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.
    Badorff C; Knowlton KU
    Med Microbiol Immunol; 2004 May; 193(2-3):121-6. PubMed ID: 12920582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of specific alphabeta+ T-cell subsets in the myocardium of patients with myocarditis and idiopathic dilated cardiomyopathy associated with Coxsackievirus B infection.
    Luppi P; Rudert W; Licata A; Riboni S; Betters D; Cotrufo M; Frati G; Condorelli G; Trucco M
    Hum Immunol; 2003 Feb; 64(2):194-210. PubMed ID: 12559622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The group B coxsackieviruses and myocarditis.
    Kim KS; Hufnagel G; Chapman NM; Tracy S
    Rev Med Virol; 2001; 11(6):355-68. PubMed ID: 11746998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulating intestinal immunity and microflora: an alternative solution to viral myocarditis?
    Qian Q; Xiong S; Xu W
    Future Microbiol; 2012 Oct; 7(10):1207-16. PubMed ID: 23030425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.